Structure‐Based Approaches to Target Fishing and Ligand Profiling
暂无分享,去创建一个
[1] Ruben Abagyan,et al. Nuclear hormone receptor targeted virtual screening. , 2003, Journal of medicinal chemistry.
[2] H. Wolfson,et al. Recognition of Functional Sites in Protein Structures☆ , 2004, Journal of Molecular Biology.
[3] Didier Rognan,et al. sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank , 2006, J. Chem. Inf. Model..
[4] G. Klebe,et al. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. , 2004, Journal of medicinal chemistry.
[5] Lei Xie,et al. Detecting evolutionary relationships across existing fold space, using sequence order-independent profile–profile alignments , 2008, Proceedings of the National Academy of Sciences.
[6] Jian Wang,et al. In Silico Elucidation of the Molecular Mechanism Defining the Adverse Effect of Selective Estrogen Receptor Modulators , 2007, PLoS Comput. Biol..
[7] S. Ekins,et al. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling , 2007, British journal of pharmacology.
[8] Satoshi Niijima,et al. GLIDA: GPCR—ligand database for chemical genomics drug discovery—database and tools update , 2007, Nucleic Acids Res..
[9] Irini Akritopoulou-Zanze,et al. Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors. , 2009, Drug discovery today.
[10] Adrian H Elcock,et al. Progress toward virtual screening for drug side effects , 2002, Proteins.
[11] Jing Chen,et al. Pocket v.2: Further Developments on Receptor-Based Pharmacophore Modeling , 2006, J. Chem. Inf. Model..
[12] G. Schneider,et al. PocketPicker: analysis of ligand binding-sites with shape descriptors , 2007, Chemistry Central Journal.
[13] Philip E. Bourne,et al. A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites , 2007, BMC Bioinformatics.
[14] Jean-Philippe Vert,et al. Virtual screening of GPCRs: An in silico chemogenomics approach , 2008, BMC Bioinformatics.
[15] Scott Boyer,et al. Ligand-Based Approach to In Silico Pharmacology: Nuclear Receptor Profiling , 2006, J. Chem. Inf. Model..
[16] Ajay N. Jain,et al. Robust ligand-based modeling of the biological targets of known drugs. , 2006, Journal of medicinal chemistry.
[17] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[18] Andreas Bender,et al. "Bayes Affinity Fingerprints" Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept? , 2006, J. Chem. Inf. Model..
[19] Philip E. Bourne,et al. Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis , 2009, PLoS Comput. Biol..
[20] Xiaomin Luo,et al. PDTD: a web-accessible protein database for drug target identification , 2008, BMC Bioinformatics.
[21] J M Blaney,et al. A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.
[22] Jordi Mestres,et al. SHED: Shannon Entropy Descriptors from Topological Feature Distributions , 2006, J. Chem. Inf. Model..
[23] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[24] Thierry Langer,et al. Molecule-pharmacophore superpositioning and pattern matching in computational drug design. , 2008, Drug discovery today.
[25] Valentin A. Ilyin,et al. LigBase: a database of families of aligned ligand binding sites in known protein sequences and structures , 2002, Bioinform..
[26] Didier Rognan,et al. Customizing G Protein-coupled receptor models for structure-based virtual screening. , 2009, Current pharmaceutical design.
[27] David A. Gough,et al. Virtual Screen for Ligands of Orphan G Protein-Coupled Receptors , 2005, J. Chem. Inf. Model..
[28] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[29] G. Klebe,et al. A new method to detect related function among proteins independent of sequence and fold homology. , 2002, Journal of molecular biology.
[30] Anne Mai Wassermann,et al. Ligand Prediction for Orphan Targets Using Support Vector Machines and Various Target-Ligand Kernels Is Dominated by Nearest Neighbor Effects , 2009, J. Chem. Inf. Model..
[31] Gilles Marcou,et al. Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints , 2007, J. Chem. Inf. Model..
[32] Christopher R. Corbeil,et al. Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go , 2008, British journal of pharmacology.
[33] Jarl E. S. Wikberg,et al. Interaction Model Based on Local Protein Substructures Generalizes to the Entire Structural Enzyme-Ligand Space , 2008, J. Chem. Inf. Model..
[34] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .
[35] Burkhard Rost,et al. Structural genomics is the largest contributor of novel structural leverage , 2009, Journal of Structural and Functional Genomics.
[36] Z. Deng,et al. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. , 2006, Journal of medicinal chemistry.
[37] B. Shoichet,et al. Flexible ligand docking using conformational ensembles , 1998, Protein science : a publication of the Protein Society.
[38] Irwin D. Kuntz,et al. Virtual Screening of Combinatorial Libraries across a Gene Family: in Search of Inhibitors of Giardia lamblia Guanine Phosphoribosyltransferase , 2001, Antimicrobial Agents and Chemotherapy.
[39] Thierry Langer,et al. Parallel Screening: A Novel Concept in Pharmacophore Modeling and Virtual Screening , 2006, J. Chem. Inf. Model..
[40] D. J. Price,et al. Assessing scoring functions for protein-ligand interactions. , 2004, Journal of medicinal chemistry.
[41] Kalidas Yeturu,et al. PocketMatch: A new algorithm to compare binding sites in protein structures , 2008, BMC Bioinformatics.
[42] I. Kuntz,et al. Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[43] Didier Rognan,et al. In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. , 2006, Journal of medicinal chemistry.
[44] Somesh D. Sharma,et al. Managing protein flexibility in docking and its applications. , 2009, Drug discovery today.
[45] Gilles Marcou,et al. Hot-Spots-Guided Receptor-Based Pharmacophores (HS-Pharm): A Knowledge-Based Approach to Identify Ligand-Anchoring Atoms in Protein Cavities and Prioritize Structure-Based Pharmacophores , 2008, J. Chem. Inf. Model..
[46] Richard A. Lewis,et al. Three-dimensional pharmacophore methods in drug discovery. , 2010, Journal of medicinal chemistry.
[47] Jian Zhang,et al. Peptide deformylase is a potential target for anti‐Helicobacter pylori drugs: Reverse docking, enzymatic assay, and X‐ray crystallography validation , 2006, Protein science : a publication of the Protein Society.
[48] Gerhard Klebe,et al. Relibase: design and development of a database for comprehensive analysis of protein-ligand interactions. , 2003, Journal of molecular biology.
[49] L. Wodicka,et al. A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.
[50] Q. Do,et al. Reverse Pharmacognosy: Application of Selnergy, a New Tool for Lead Discovery. The Example of ε-Viniferin , 2005 .
[51] Thierry Langer,et al. LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..
[52] Hugo Kubinyi,et al. Success Stories of Computer‐Aided Design , 2006 .
[53] N. Gold,et al. Fold independent structural comparisons of protein-ligand binding sites for exploring functional relationships. , 2006, Journal of molecular biology.
[54] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[55] Andreas Bender,et al. Ligand-Target Prediction Using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics , 2008, J. Chem. Inf. Model..
[56] Joannis Apostolakis,et al. GlamDock: Development and Validation of a New Docking Tool on Several Thousand Protein-Ligand Complexes , 2007, J. Chem. Inf. Model..
[57] Xiaomin Luo,et al. TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..
[58] L. Meijer,et al. Inverse in silico screening for identification of kinase inhibitor targets. , 2007, Chemistry & biology.
[59] Michael M. Mysinger,et al. Automated Docking Screens: A Feasibility Study , 2009, Journal of medicinal chemistry.
[60] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[61] Didier Rognan,et al. Ranking Targets in Structure-Based Virtual Screening of Three-Dimensional Protein Libraries: Methods and Problems , 2008, J. Chem. Inf. Model..
[62] D. Rognan. Chemogenomic approaches to rational drug design , 2007, British journal of pharmacology.
[63] Lin He,et al. Harvesting Candidate Genes Responsible for Serious Adverse Drug Reactions from a Chemical-Protein Interactome , 2009, PLoS Comput. Biol..
[64] I. Muegge,et al. Virtual screening for kinase targets. , 2004, Current medicinal chemistry.
[65] K. Kinoshita,et al. Identification of protein functions from a molecular surface database, eF-site , 2004, Journal of Structural and Functional Genomics.
[66] Renxiao Wang,et al. The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. , 2004, Journal of medicinal chemistry.
[67] Elaine C. Meng,et al. Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design. , 1997 .
[68] Thierry Langer,et al. Pharmacophore modeling and parallel screening for PPAR ligands , 2007, J. Comput. Aided Mol. Des..
[69] Pierre Acklin,et al. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..
[70] G. Schneider,et al. Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation , 2009, Proceedings of the National Academy of Sciences.
[71] Meir Glick,et al. Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..
[72] E. Kellenberger,et al. A simple and fuzzy method to align and compare druggable ligand‐binding sites , 2008, Proteins.
[73] Thomas Lengauer,et al. A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.
[74] R. Abagyan,et al. Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes* , 2005, Molecular & Cellular Proteomics.
[75] Thierry Langer,et al. In silico Target Fishing for Rationalized Ligand Discovery Exemplified on Constituents of Ruta graveolens , 2008, Planta medica.
[76] Nathanael Weill,et al. Alignment-Free Ultra-High-Throughput Comparison of Druggable Protein-Ligand Binding Sites , 2010, J. Chem. Inf. Model..
[77] C L Brooks,et al. Ligand-protein database: linking protein-ligand complex structures to binding data. , 2001, Journal of medicinal chemistry.
[78] Vladimir Poroikov,et al. Robustness of Biological Activity Spectra Predicting by Computer Program PASS for Noncongeneric Sets of Chemical Compounds , 2000, J. Chem. Inf. Comput. Sci..
[79] T. Klabunde. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands , 2007, British journal of pharmacology.
[80] Luc Morin-Allory,et al. Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzin. , 2007, Planta medica.
[81] Sean Ekins,et al. Computer Applications in Pharmaceutical Research and Development , 2008 .
[82] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[83] Haruki Nakamura,et al. Remediation of the protein data bank archive , 2007, Nucleic Acids Res..
[84] Malin M. Young,et al. Design, docking, and evaluation of multiple libraries against multiple targets , 2001, Proteins.
[85] J. Bajorath. Computational analysis of ligand relationships within target families. , 2008, Current opinion in chemical biology.
[86] N. Paul,et al. Recovering the true targets of specific ligands by virtual screening of the protein data bank , 2004, Proteins.
[87] B. Shoichet,et al. Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes. , 2003, Journal of medicinal chemistry.
[88] Thierry Langer,et al. Parallel Screening and Activity Profiling with HIV Protease Inhibitor Pharmacophore Models , 2007, J. Chem. Inf. Model..
[89] Didier Rognan,et al. How to Measure the Similarity Between Protein Ligand-Binding Sites? , 2008 .
[90] Jan M. Kriegl,et al. Form follows function: Shape analysis of protein cavities for receptor‐based drug design , 2009, Proteomics.
[91] Nathanael Weill,et al. Development and Validation of a Novel Protein-Ligand Fingerprint To Mine Chemogenomic Space: Application to G Protein-Coupled Receptors and Their Ligands , 2009, J. Chem. Inf. Model..